These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2016819)

  • 41. Banning pens and pads misses the main point.
    Terry SF; Burke W
    Am J Bioeth; 2003; 3(3):63-5. PubMed ID: 14594500
    [No Abstract]   [Full Text] [Related]  

  • 42. Updated estimates of pharmaceutical company payments to physicians in Vermont.
    Ross JS; Nazem AG; Lurie P; Lackner JE; Krumholz HM
    JAMA; 2008 Nov; 300(17):1998-2000. PubMed ID: 18984886
    [No Abstract]   [Full Text] [Related]  

  • 43. Physician-industry relations--will fewer gifts make a difference?
    Steinbrook R
    N Engl J Med; 2009 Feb; 360(6):557-9. PubMed ID: 19196671
    [No Abstract]   [Full Text] [Related]  

  • 44. Medical students protest perks from drug companies.
    Opar A
    Nat Med; 2006 Oct; 12(10):1104. PubMed ID: 17024192
    [No Abstract]   [Full Text] [Related]  

  • 45. Of mugs and marketing.
    Goldstein JH
    JAMA; 1991 May; 265(18):2391-2. PubMed ID: 2016837
    [No Abstract]   [Full Text] [Related]  

  • 46. Who pays for the pizza? Redefining the relationships between doctors and drug companies. 1: entanglement.
    Moynihan R
    BMJ; 2003 May; 326(7400):1189-92. PubMed ID: 12775621
    [TBL] [Abstract][Full Text] [Related]  

  • 47. World Medical Association reviews doctors' links with drug companies.
    Mayor S
    BMJ; 2003 May; 326(7400):1165. PubMed ID: 12775604
    [No Abstract]   [Full Text] [Related]  

  • 48. Nurses and the pharmaceutical industry: part 2.
    Olsen DP
    Am J Nurs; 2009 Feb; 109(2):86-7. PubMed ID: 19300016
    [No Abstract]   [Full Text] [Related]  

  • 49. [Effects of a mandatory guideline that prohibit hospital doctors from accepting any form of benefits in any form from the pharmaceutical industry].
    Gundermann C; Meier-Hellmann A; Bauer M; Hartmann M
    Dtsch Med Wochenschr; 2010 May; 135(3):67-70. PubMed ID: 20077378
    [TBL] [Abstract][Full Text] [Related]  

  • 50. AMA forges ahead. Unveiling of educational campaign paid by drug industry triggers new criticism.
    Romano M
    Mod Healthc; 2001 Sep; 31(37):22-3. PubMed ID: 11573355
    [No Abstract]   [Full Text] [Related]  

  • 51. Lunch with Lilly: who pays?
    Strong C
    Am J Bioeth; 2003; 3(3):62-3. PubMed ID: 14594499
    [No Abstract]   [Full Text] [Related]  

  • 52. Financial conflicts of interest in physicians' relationships with the pharmaceutical industry--self-regulation in the shadow of federal prosecution.
    Studdert DM; Mello MM; Brennan TA
    N Engl J Med; 2004 Oct; 351(18):1891-900. PubMed ID: 15509824
    [No Abstract]   [Full Text] [Related]  

  • 53. Response to open peer commentaries on "The pitfalls of deducing ethics from economics: why the Association of American Medical Colleges is wrong about pharmaceutical detailing".
    Huddle TS
    Am J Bioeth; 2010 Jan; 10(1):W1-3. PubMed ID: 20077322
    [No Abstract]   [Full Text] [Related]  

  • 54. Permanent injunction order against AMA.
    Getzendanner S
    JAMA; 1988 Jan; 259(1):81-2. PubMed ID: 3334777
    [No Abstract]   [Full Text] [Related]  

  • 55. Guidelines on gifts to physicians from industry: an update.
    Council on Ethical and Judicial Affairs of the American Medical Association
    Food Drug Law J; 2001; 56(1):27-40. PubMed ID: 11942349
    [No Abstract]   [Full Text] [Related]  

  • 56. Managed care cost containment involving prescription drugs. American Medical Association, Council on Ethical and Judicial Affairs.
    Food Drug Law J; 1998; 53(1):25-34. PubMed ID: 11795334
    [No Abstract]   [Full Text] [Related]  

  • 57. Sunlight as disinfectant--new rules on disclosure of industry payments to physicians.
    Rosenthal MB; Mello MM
    N Engl J Med; 2013 May; 368(22):2052-4. PubMed ID: 23718162
    [No Abstract]   [Full Text] [Related]  

  • 58. The Medical Council of India guidelines on industry-physician relationship: breaking the conspiracy of silence.
    Nagral J; Roy N
    Natl Med J India; 2010; 23(2):69-71. PubMed ID: 20925200
    [No Abstract]   [Full Text] [Related]  

  • 59. US specialty societies are urged to adopt code on relations with industry.
    Tanne JH
    BMJ; 2010 Apr; 340():c2246. PubMed ID: 20418248
    [No Abstract]   [Full Text] [Related]  

  • 60. Lets Do Lunch? The ethics of accepting gifts from the pharmaceutical industry.
    Hagen B; Pijl-Zieber EM; Souveny K; Lacroix A
    Can Nurse; 2008 Apr; 104(4):30-5. PubMed ID: 18488765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.